Literature DB >> 23428100

Etiology, diagnosis and management of chronic rhinosinusitis.

R Peter Manes1, Pete S Batra.   

Abstract

Chronic rhinosinusitis (CRS) is a common health care problem, yet many aspects of this diagnosis remain poorly understood. Its etiology is often debated and remains a significant area of research. The diagnosis of CRS is based on subjective symptoms, duration of symptoms and objective evidence of inflammation. Each of these criteria must be met to make a diagnosis of CRS. Management of CRS often involves a combination of systemic and topical therapies with surgery reserved for patients who fail medical therapy. This review provides a comprehensive view of the etiology, diagnosis and management of CRS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428100     DOI: 10.1586/eri.12.151

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  4 in total

1.  Significance of Blood Eosinophil Count in Patients with Chronic Rhinosinusitis with Nasal Polyposis.

Authors:  Ammu Sreeparvathi; Lathi Kumari Kalyanikuttyamma; Madhumita Kumar; Nandagopan Sreekumar; Narendrakumar Veerasigamani
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Relationship between Sinonasal Anatomical Variations and Symptom Severity in Patients with Chronic Rhinosinusitis.

Authors:  Yakubu Bababa Shirama; Auwal Adamu; Sa'idu Sule Ahmed; Kufre Robert Iseh; Sadisu Muhammad Ma'aji; Sule Muhammad Baba
Journal:  J West Afr Coll Surg       Date:  2022-03-05

3.  The effectiveness topical amphotericin B in the management of chronic rhinosinusitis: a meta-analysis.

Authors:  Tianqi Wang; Jinfei Su; Yanjun Feng
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-13       Impact factor: 2.503

4.  Intra-operative biopsy in chronic sinusitis detects pathogenic Escherichia coli that carry fimG/H, fyuA and agn43 genes coding biofilm formation.

Authors:  Michał Michalik; Alfred Samet; Andrzej Marszałek; Beata Krawczyk; Roman Kotłowski; Alex Nowicki; Tomasz Anyszek; Stella Nowicki; Józef Kur; Bogdan Nowicki
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.